Inhibition of endothelin-1 with darusentan: a novel antihypertensive approach for the treatment of resistant hypertension

Author： Weiss Robert Graybill Christopher A Linseman Jennifer Warren Marshelle

Publisher： Future Medicine

ISSN： 1475-0708

Source： Therapy, Vol.5, Iss.6, 2008-11, pp. : 739-750

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

IPRONIAZID IN THE TREATMENT OF RESISTANT HYPERTENSION

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 8, Iss. 6, 1960-06 ,pp. : 454-462

John Wiley & Sons Inc

Access to resources Recommend Favorite

Endothelin receptor antagonism in pulmonary arterial hypertension – a role for selective ET_A inhibition?

By Jacobs Avrum Preston Ioana R. Gomberg-Maitland Mardi

Current Medical Research and Opinion, Vol. 22, Iss. 12, 2006-12 ,pp. : 2567-2574

Informa Healthcare

Access to resources Recommend Favorite

Proteinuria and Renal Function During Antihypertensive Treatment for Essential Hypertension

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 28, Iss. 3, 1980-03 ,pp. : 114-117

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of Antihypertensive Treatment on Left Ventricular Hypertrophy in Patients with Essential Hypertension

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 27, Iss. 11, 1979-11 ,pp. : 500-506

John Wiley & Sons Inc

Access to resources Recommend Favorite

HYPERTENSION IN ELDERLY PATIENTS: TREATMENT WITH A FIXED COMBINATION OF ANTIHYPERTENSIVE DRUGS

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 6, Iss. 10, 1958-10 ,pp. : 770-774

John Wiley & Sons Inc

Access to resources Recommend Favorite